Literature DB >> 11507081

Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.

S Aznavoorian1, B A Moore, L D Alexander-Lister, S L Hallit, L J Windsor, J A Engler.   

Abstract

Oral squamous cell carcinomas are highly invasive lesions that destroy adjacent tissues and invade bone and muscle, which is most likely the result of matrix metalloproteinase (MMP) activity. We examined three cell lines derived from squamous cell carcinoma of the tongue for their intrinsic capacities to degrade interstitial collagen with the goal of identifying the matrix-degrading enzymes. SCC-25 and SCC-15 cells degrade reconstituted fibrillar type I collagen in the absence of exogenous growth factors or cytokines when seeded as a colony on dried films. Degradation is confined to the subjacent matrix, is enhanced 2-3-fold by phorbol ester, and is strictly MMP-dependent, as it is blocked by BB-94 and tissue inhibitor of metalloproteinases-2 but not by inhibitors of serine and cysteine proteinases. Both cell lines express active (M(r) 57,000) membrane type I-MMP (MT1-MMP) on their surfaces, as detected by surface biotinylation and immunoprecipitation. Concomitantly, both cell lines activate endogenous MMP-2 when cultured on type I collagen films, as assessed by zymography. Phorbol ester treatment enhances collagen-induced MMP-2 activation, which is accompanied by the appearance of a surface-labeled M(r) 43,000 form of MT1-MMP. Treatment of cells with a synthetic furin inhibitor, which inhibits processing of the MT1-MMP zymogen, blocks collagen degradation. In contrast, CAL 27 cells do not degrade collagen under either basal or phorbol 12-myristate 13-acetate-stimulated conditions. Although proMT1-MMP (M(r) 63,000/65,000) is detectable in these cells by immunoblot analysis, they express greatly reduced levels of active MT1-MMP on their surfaces relative to SCC-25 and SCC-15 cells. Correspondingly, CAL 27 cells cultured on collagen express neither latent nor active gelatinases. Immunoblots of lysates and conditioned media revealed the constitutive expression of proMMP-1 and proMMP-13 in all three cell lines. We conclude that in the absence of exogenous growth factors or accessory stromal cells, degradation of interstitial collagen by oral squamous cell carcinoma cells requires a threshold level of active MT1-MMP on cell surfaces.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507081

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Furin at the cutting edge: from protein traffic to embryogenesis and disease.

Authors:  Gary Thomas
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

2.  Fabrication and characterization of medical grade polyurethane composite catheters for near-infrared imaging.

Authors:  André T Stevenson; Laura M Reese; Tanner K Hill; Jeffrey McGuire; Aaron M Mohs; Raj Shekhar; Lissett R Bickford; Abby R Whittington
Journal:  Biomaterials       Date:  2015-04-07       Impact factor: 12.479

3.  Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases.

Authors:  Hazem Abdul-Hussien; Ratna G V Soekhoe; Ekkehard Weber; Jan H von der Thüsen; Robert Kleemann; Adri Mulder; J Hajo van Bockel; Roeland Hanemaaijer; Jan H N Lindeman
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

4.  Fibroblasts and extracellular matrix differently modulate MMP activation by primary and metastatic head and neck cancer cells.

Authors:  Sittichai Koontongkaew; Panomwat Amornphimoltham; Paopanga Monthanpisut; Theeranuch Saensuk; Montira Leelakriangsak
Journal:  Med Oncol       Date:  2011-03-06       Impact factor: 3.064

5.  Melanoma-Induced Reprogramming of Schwann Cell Signaling Aids Tumor Growth.

Authors:  Galina V Shurin; Oleg Kruglov; Fei Ding; Yan Lin; Xingxing Hao; Anton A Keskinov; Zhaoyang You; Anna E Lokshin; William A LaFramboise; Louis D Falo; Michael R Shurin; Yuri L Bunimovich
Journal:  Cancer Res       Date:  2019-03-26       Impact factor: 12.701

6.  Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha.

Authors:  Keita Itatsu; Motoko Sasaki; Junpei Yamaguchi; Shusaku Ohira; Akira Ishikawa; Hiroko Ikeda; Yasunori Sato; Kenichi Harada; Yoh Zen; Hiroshi Sato; Tetsuo Ohta; Masato Nagino; Yuji Nimura; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

7.  Cathepsin K is the principal protease in giant cell tumor of bone.

Authors:  Jan H N Lindeman; Roeland Hanemaaijer; Adri Mulder; P D Sander Dijkstra; Károly Szuhai; Dieter Bromme; Jan H Verheijen; Pancras C W Hogendoorn
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

8.  The inactive 44-kDa processed form of membrane type 1 matrix metalloproteinase (MT1-MMP) enhances proteolytic activity via regulation of endocytosis of active MT1-MMP.

Authors:  Jin-Ah Cho; Pamela Osenkowski; Huiren Zhao; Seaho Kim; Marta Toth; Kristina Cole; Amro Aboukameel; Allen Saliganan; Lucia Schuger; R Daniel Bonfil; Rafael Fridman
Journal:  J Biol Chem       Date:  2008-04-15       Impact factor: 5.157

9.  Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation.

Authors:  L R McNally; E L Rosenthal; W Zhang; D J Buchsbaum
Journal:  Cancer Gene Ther       Date:  2008-10-10       Impact factor: 5.987

10.  MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells.

Authors:  K L Sodek; M J Ringuette; T J Brown
Journal:  Br J Cancer       Date:  2007-07-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.